Sun M, Kim D, Baek Y, Lee H
Antioxidants (Basel). 2024; 13(10).
PMID: 39456471
PMC: 11504132.
DOI: 10.3390/antiox13101218.
Alotaibi B, Hakami M, Hazazi A, Alsaiari A, Khalid M, Beg A
Saudi J Biol Sci. 2024; 31(8):104035.
PMID: 38934013
PMC: 11201349.
DOI: 10.1016/j.sjbs.2024.104035.
Salih O, Al-Shaer M, Basheer H
ACS Omega. 2024; 9(12):13928-13950.
PMID: 38559989
PMC: 10975593.
DOI: 10.1021/acsomega.3c09212.
Afshari H, Noori S, Zarghi A
Inflammopharmacology. 2023; 31(5):2541-2555.
PMID: 37452228
DOI: 10.1007/s10787-023-01281-2.
Liu X, Qi M, Li X, Wang J, Wang M
J Ovarian Res. 2023; 16(1):47.
PMID: 36859398
PMC: 9976389.
DOI: 10.1186/s13048-023-01120-6.
Dibenzylideneacetone Induces Apoptosis in Cervical Cancer Cells through Ros-Mediated Mitochondrial Damage.
Zani A, Zani C, Din Z, Rodrigues-Filho E, Ueda-Nakamura T, Garcia F
Antioxidants (Basel). 2023; 12(2).
PMID: 36829876
PMC: 9952489.
DOI: 10.3390/antiox12020317.
In Vitro Cytotoxic Effects and Mechanisms of Action of Eleutherine Isolated from Bulb in Rat Glioma C6 Cells.
Shinkai V, Sampaio I, Dos Santos E, Galue-Parra A, Ferreira D, Baliza D
Molecules. 2022; 27(24).
PMID: 36557983
PMC: 9785660.
DOI: 10.3390/molecules27248850.
MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer.
Gullu N, Smith J, Herrmann P, Stein U
Nutrients. 2022; 14(22).
PMID: 36432477
PMC: 9692505.
DOI: 10.3390/nu14224792.
Review On the Effects Curcumin on Tumors of the Reproductive System: Curcumin and Reproductive Tumors.
Zahra M, Mostafa T, Yasaman H, Amin D, Mostafa S, Seyed Sina N
Galen Med J. 2022; 10:1-8.
PMID: 35855104
PMC: 9261988.
DOI: 10.31661/gmj.v10i0.2178.
In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review.
Zhang Q, Wu L
J Oncol. 2022; 2022:7277562.
PMID: 35237323
PMC: 8885194.
DOI: 10.1155/2022/7277562.
(5E,7E)-4,5,6 Trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5,7-dienoate from (L.) Inhibits Ovarian Cancer Cell Growth by Controlling Apoptotic and Metastatic Signaling Mechanisms.
Palanisamy C, Cui B, Zhang H, Jayaraman S, Rajagopal P, Veeraraghavan V
Bioinorg Chem Appl. 2022; 2022:4464056.
PMID: 35132312
PMC: 8817890.
DOI: 10.1155/2022/4464056.
The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence.
Rezaei-Tazangi F, Roghani-Shahraki H, Ghaffari M, Zadeh F, Boostan A, Arefnezhad R
Pharmaceuticals (Basel). 2021; 14(12).
PMID: 34959716
PMC: 8705681.
DOI: 10.3390/ph14121315.
Therapeutic role of curcumin and its novel formulations in gynecological cancers.
Pourhanifeh M, Darvish M, Tabatabaeian J, Fard M, Mottaghi R, Azadchehr M
J Ovarian Res. 2020; 13(1):130.
PMID: 33148295
PMC: 7643381.
DOI: 10.1186/s13048-020-00731-7.
Novel Insight to Neuroprotective Potential of Curcumin: A Mechanistic Review of Possible Involvement of Mitochondrial Biogenesis and PI3/Akt/ GSK3 or PI3/Akt/CREB/BDNF Signaling Pathways.
Kandezi N, Mohammadi M, Ghaffari M, Gholami M, Motaghinejad M, Safari S
Int J Mol Cell Med. 2020; 9(1):1-32.
PMID: 32832482
PMC: 7422850.
DOI: 10.22088/IJMCM.BUMS.9.1.1.
Growth-Inhibitory Effect of Chitosan-Coated Liposomes Encapsulating Curcumin on MCF-7 Breast Cancer Cells.
Hasan M, Elkhoury K, Belhaj N, Kahn C, Tamayol A, Barberi-Heyob M
Mar Drugs. 2020; 18(4).
PMID: 32316578
PMC: 7230998.
DOI: 10.3390/md18040217.
Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines.
Koroth J, Nirgude S, Tiwari S, Gopalakrishnan V, Mahadeva R, Kumar S
BMC Complement Altern Med. 2019; 19(1):273.
PMID: 31638975
PMC: 6802352.
DOI: 10.1186/s12906-019-2685-3.
Curcumin-Mediated Induction of Apoptosis in Human Glioma CHME Cells.
Zhang Y, Tu L, Zhou X, Li B
Med Sci Monit Basic Res. 2018; 24:216-224.
PMID: 30531680
PMC: 6301257.
DOI: 10.12659/MSMBR.912313.
Targeting Inflammation in Ovarian Cancer Through Natural Antioxidants, Potential Therapeutic and Preventive Implications.
Singh M, Shankar A, Dhiman K, Kotecha R, Rath G
Asian Pac J Cancer Prev. 2018; 19(10):2687-2690.
PMID: 30360591
PMC: 6291036.
DOI: 10.22034/APJCP.2018.19.10.2687.
Anticancer Activity of Curcumin-Loaded PLGA Nanoparticles on PC3 Prostate Cancer Cells.
Azandeh S, Abbaspour M, Khodadadi A, Khorsandi L, Orazizadeh M, Heidari-Moghadam A
Iran J Pharm Res. 2017; 16(3):868-879.
PMID: 29201078
PMC: 5610743.
Novel strategies to prevent the development of multidrug resistance (MDR) in cancer.
Wang J, Seebacher N, Shi H, Kan Q, Duan Z
Oncotarget. 2017; 8(48):84559-84571.
PMID: 29137448
PMC: 5663620.
DOI: 10.18632/oncotarget.19187.